HORIZON (OP-106): Melflufen plus dexamethasone in 55 patients with relapsed/refractory multiple myeloma with extramedullary disease-subgroup analysis Meeting Abstract
| Authors: | Richardson, P.; Mateos, M. V.; Oriol, A.; Larocca, A.; Cavo, M.; Rodriguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J.; Hassoun, H.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Puig, N.; Zamagni, E.; Thuresson, M.; Harmenberg, J.; Harlin, O.; Blade, J. |
| Abstract Title: | HORIZON (OP-106): Melflufen plus dexamethasone in 55 patients with relapsed/refractory multiple myeloma with extramedullary disease-subgroup analysis |
| Meeting Title: | 2021 Lymphoma, Leukemia & Myeloma Congress |
| Journal Title: | American Journal of Hematology |
| Volume: | 96 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Oct 19-23 |
| Meeting Location: | Virtual |
| ISSN: | 0361-8609 |
| Publisher: | John Wiley & Sons, Inc. |
| Date Published: | 2021-10-01 |
| Start Page: | S10 |
| Language: | English |
| ACCESSION: | WOS:000707408900012 |
| PROVIDER: | wos |
| PUBMED: | 34652034 |
| DOI: | 10.1002/ajh.26351 |
| Notes: | Meeting Abstract: PO-10 -- Source: Wos |
